Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australasian Leukaemia and Lymphoma Group (ALLG)
Scientific Title
A Strategy of High-Dose Lenalidomide in Combination with Epigenetic Therapies for Relapsed or Refractory Acute Myeloid Leukaemia (AML)- Phase I